The applicant, who has multiple sclerosis, filed a human rights application alleging discrimination after the respondent denied OHIP funding for a CCSVI angioplasty procedure.
The respondent had refused funding on the basis that the treatment was experimental, a decision upheld by the Health Services Appeal and Review Board (HSARB).
The respondent requested the Tribunal dismiss the application under s. 45.1 of the Human Rights Code.
The Tribunal found that the HSARB had appropriately dealt with the issue of whether the treatment was experimental.
Furthermore, the Tribunal concluded the application had no reasonable prospect of success, as the applicant could not show she was treated differently from any other person seeking funding for an experimental treatment.